Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury.
about
Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.Substance P modulates colitis-associated fibrosisEffects of low-level laser therapy on ROS homeostasis and expression of IGF-1 and TGF-β1 in skeletal muscle during the repair process.Update on acute lung injury and critical care medicine 2009.Role of urokinase plasminogen activator receptor-associated protein in mouse lungmiR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?Involvement of Igf1r in Bronchiolar Epithelial Regeneration: Role during Repair Kinetics after Selective Club Cell Ablation.Effect of insulin-like growth factor blockade on hyperoxia-induced lung injury.Sequential expression of IGF-IB followed by active TGF-β1 induces synergistic pulmonary fibroproliferation in vivo.Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a.Role of IGF-1 pathway in lung fibroblast activation.Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.The possible potential therapeutic targets for drug induced gingival overgrowth.Growth factors and cytokines in acute lung injury.Klotho Regulates Cigarette Smoke-Induced Autophagy: Implication in Pathogenesis of COPD.Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.In vivo targeting of alveolar macrophages via RAFT-based glycopolymers.IGF1R deficiency attenuates acute inflammatory response in a bleomycin-induced lung injury mouse model.Enhanced production of IGF-I in the lungs of fibroproliferative ARDS patients.Fra-2 negatively regulates postnatal alveolar septation by modulating myofibroblast function.Early Detection of Urinary Proteome Biomarkers for Effective Early Treatment of Pulmonary Fibrosis in a Rat Model.GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.The Bleomycin Model of Pulmonary Fibrosis.Attenuated airway hyperresponsiveness and mucus secretion in HDM-exposed Igf1r-deficient mice.IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.The IGF-I/IGF-R1 pathway regulates postnatal lung growth and is a nonspecific regulator of alveologenesis in the neonatal rat.miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.The levels of pro-fibrotic cytokines in pulmonary tuberculosis with minimal and extensive lesions.
P2860
Q34190597-AD08D883-D846-48ED-B74B-3D8E20B49E36Q34254416-B92EBD6A-92B4-42DB-B9FF-F8E3BFA27F3CQ34310013-470787A1-03A7-43FB-8D7E-ABEB1C262154Q35716122-563C4F52-4E76-4DC3-84CB-93386CF8740EQ35813891-070C3E70-449B-49DC-AA8D-AF8177B8B7D4Q35949070-393A7C1D-D1AE-48DD-B497-B8F28CA3C6A7Q35977261-0EB9AA76-C5BF-440C-AA9E-2876B20ED1A6Q36197145-C4DE3084-009B-47BB-90DF-51E4F94ADFFBQ36370176-D05329FA-57F0-4914-8324-46C4A527ECABQ36454392-B843D4AD-3C54-4585-96BA-B38DEB40EFFBQ36913772-61C435B2-18DA-42A4-BE48-9D2431D296A2Q37094220-B3879C75-2F2A-482A-B53A-5FD5ACF6EACDQ37343091-3CE79624-B5B0-4217-8BC2-1A52C0ECA144Q37724033-31045AC8-DF8E-4943-8052-4FD2EF8BF4BFQ37782153-7E6AC2A8-8D3F-4FAA-A2ED-A58C9C70097DQ38108291-024DB67C-45AC-4290-BAD7-242CA47ED252Q38112030-4A05EE7D-B9CF-4785-9FFC-E0A5869BF8FDQ38872007-4BE0B22A-E8C5-413D-9836-21807857C63DQ39580270-DB29076A-AED7-42B3-B805-E8A564B9FCB3Q39590398-B9836F7A-AB9B-4902-8D44-0685A25D7D3FQ41025366-7E86C9EF-3BBE-473E-AD5B-F6E4F573A3AFQ41964325-BBC85D56-A762-4D15-9E4D-328AB99150FCQ46539847-051515B0-0C56-4B41-A8B0-00BE226EFC61Q47448022-D3DAE46C-4B2A-4578-8E28-5817643A8767Q47663299-9326AE21-8E60-4B60-ABC0-BB2692DA2413Q47794291-DF5DD54B-D3F1-480B-B8F8-A3BDC5DDE73FQ47857483-0DF6F535-A475-4F7F-B90D-FEC33DDD1086Q47933314-2827D581-9E47-4E0C-841C-2187B8282620Q48156634-EA14EBFE-6710-4030-ACB3-D71E26E40793Q54446403-FBA5AF49-BB51-4C80-AAE4-41872DE4A4F1Q55026266-A017F1C7-112D-4B41-864F-5D364A2AEDBEQ55207049-AF0E6ACF-0AD7-47FA-8404-5F6FB3FC596E
P2860
Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Insulin-like growth factor-I r ...... in mouse model of lung injury.
@en
Insulin-like growth factor-I r ...... in mouse model of lung injury.
@nl
type
label
Insulin-like growth factor-I r ...... in mouse model of lung injury.
@en
Insulin-like growth factor-I r ...... in mouse model of lung injury.
@nl
prefLabel
Insulin-like growth factor-I r ...... in mouse model of lung injury.
@en
Insulin-like growth factor-I r ...... in mouse model of lung injury.
@nl
P2093
P2860
P1476
Insulin-like growth factor-I r ...... in mouse model of lung injury.
@en
P2093
Donald A Sunde
Isham Huizar
Jung-Eun Choi
Kathy L Haugk
Lynn M Schnapp
Ragini Vittal
Stephen R Plymate
Sung-Soon Lee
Victor J Thannickal
P2860
P304
P356
10.1164/RCCM.200802-228OC
P407
P577
2008-11-14T00:00:00Z